Therapeutic Areas: Otolaryngology (Ear, Nose, Throat) | Pulmonary/Respiratory Diseases | Immunology | Infections and Infectious Diseases

Allergy Clinical Trials


A listing of Allergy medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.

Alabama

Mobile : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

California

Los Angeles : UCLA

Anti-TSLP (AMG 157) plus antigen-specific immunotherapy for induction of tolerance in individuals with cat allergy (CATNIP Study)

Wildomar : Elite Clinical Trials, Inc.

Does Your Child Suffer from Allergies or Hives?

Fresno : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Riverside : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

San Jose : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Colorado

Denver : National Jewish Health

Anti-TSLP (AMG 157) plus antigen-specific immunotherapy for induction of tolerance in individuals with cat allergy (CATNIP Study)

Illinois

Chicago : ChicagoENT

A Double-Blind, Randomised, Placebo-Controlled Multi-Centre Field Study to Assess the Efficacy and Safety of Cat-PAD Peptide Immunotherapy in Cat Allergic Subjects

Chicago : University of Chicago

Anti-TSLP (AMG 157) plus antigen-specific immunotherapy for induction of tolerance in individuals with cat allergy (CATNIP Study)

Chicago : Northwestern University

Anti-TSLP (AMG 157) plus antigen-specific immunotherapy for induction of tolerance in individuals with cat allergy (CATNIP Study)

Kentucky

Bowling Green : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Maryland

Baltimore : Johns Hopkins

Anti-TSLP (AMG 157) plus antigen-specific immunotherapy for induction of tolerance in individuals with cat allergy (CATNIP Study)

Baltimore : PAREXEL

Seasonal Allergy Eczema

Columbia : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Waldorf : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Massachusetts

Minnesota

Minneapolis : Clinical Research Institute, MN Updated

810_Cow's Milk Allergy Research Study

Minneapolis : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Missouri

St. Louis : The Clinical Research Center, LLC

Do You Suffer from Dust Mite Allergies? If so You May Quailfy for a House Dust Mite Study.

Nebraska

Papillion : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

New York

Bronx : The Harold & Muriel Block Institute for Clinical and Translational Research at Einstein & Montefiore

Diagnosis of Aspirin Hypersensitivity by Measuring Arachidonic Acid Metabolites after Low Dose Aspirin Challenge

Mineola : Winthrop University Hospital Clinical Trials Center

Children and Adolescents with Hereditary Angioedema (HAE)

Mineola : Winthrop University Hospital Clinical Trials Center

Study for adults with Hereditary Angioedema (HAE)

New York : The Rockefeller University Hospital New

Food Allergy, Phenotype, Regulation and Development of the Immune System in Adult Atopic Dermatitis Patients

Brooklyn : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Ohio

Cincinnati : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Oklahoma

Oregon

Medford : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Pennsylvania

Philadelphia : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

South Carolina

Mt. Pleasant : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Summerville : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Texas

Arlington : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Utah

Salt Lake City : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Virginia

Midlothian : Virginia Research Center

SAS115359, a Safety and Efficacy Study of Inhaled Fluticasone Propionate/Salmeterol Combination Versus Inhaled Fluticasone Propionate in the Treatment of Adolescent and Adult Subjects With Asthma.

Richmond : Virginia Research Center

SAS115359, a Safety and Efficacy Study of Inhaled Fluticasone Propionate/Salmeterol Combination Versus Inhaled Fluticasone Propionate in the Treatment of Adolescent and Adult Subjects With Asthma.

Fairfax : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Washington

Seattle : ASTHMA, Inc.

Anti-TSLP (AMG 157) plus antigen-specific immunotherapy for induction of tolerance in individuals with cat allergy (CATNIP Study)

Everett : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Wisconsin

Madison : University of Wisconsin Madison

Anti-TSLP (AMG 157) plus antigen-specific immunotherapy for induction of tolerance in individuals with cat allergy (CATNIP Study)

Argentina

Buenos Aires : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Buenos Aires : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Caba : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Caba : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Caba : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Mar del Plata : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Mendoza : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Mendoza : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Rosario : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Rosario : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

San Miguel de Tucuman : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Santa Fe : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Santa Fe : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Canada

Montreal : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Ottawa : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Quebec : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

St-Charles-Borromée : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Czech Republic

Breclav : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Brno : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Brno : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Olomouc : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Tabor : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Teplice : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Trutnov : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Denmark

Finland

Helsinki : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Tampere : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Turku : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

France

Le Kremlin Bicetre : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Marseille : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Germany

Berlin : Hospital Charité

A clinical trial to evaluate treatments using Special Medical Food for patients with Allergy or Food Allergy

Bonn : St.-Marien-Hospital

A clinical trial to evaluate treatments using Special Medical Food for patients with Allergy or Food Allergy

Frankfurt : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Grosshansdorf : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Hamburg : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Homburg : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Leipzig : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Leipzig : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Mainz : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Roth : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Rüdersdorf : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Hungary

Budapest : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Debrecen : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Godollo : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Pecs : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Torokbalint : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Israel

Haifa : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Jerusalem : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Jerusalem : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Kfar-Sava : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Petach Tikva : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Rehovot : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Italy

Messina : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Milano : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Padova : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Pisa : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Reggio Emilia : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Verona : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Korea, Republic of

Bucheon-Si : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Cheongju : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Gwangju : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Seoul : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Seoul : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Seoul : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Suwon : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Mexico

Guadalajara : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

México, D.F. : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Poland

Bialystok : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Lodz : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Portugal

Coimbra : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Lisboa : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Lisboa : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Porto : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Vila Nova de Gaia : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Romania

Brasov : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Brasov : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Brasov : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Bucharest : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Bucharest : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Bucuresti : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Bucuresti : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Cluj Napoca : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Cluj-Napoca : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Constanta : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Russian Federation

Barnaul : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Moscow : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Moscow : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Moscow : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

N.Novgorod : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Nizhny Novgorod : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Ryazan : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Sankt-Peterburg : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Saratov : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

St. Petersburg : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

St-Petersburg : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Yaroslavl : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Singapore

Singapore : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Singapore : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Singapore : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Slovakia

Bratislava : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Bratislava : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Kosice : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Nitra : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Prievidza : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Ruzomberok : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Trencin : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Spain

Granada : Biosearch S.A.

A clinical trial to evaluate treatments using Damira/Celia peptide hydrolyzed casein and Picot riz/Celia rice/Sanutri arroz for patients with Cow Milk Protein Sensitivity, Tolerance or Growth Failure

Turkey

Istanbul : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Istanbul : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Istanbul : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Izmir : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Mersin : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

United Kingdom

Birmingham : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Bradford : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

East Yorkshire : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

London : Evelina Children's Hospital - St Thomas' Hospital

A clinical trial to evaluate treatments using Special Medical Food for patients with Allergy or Food Allergy

Merthyr Tydfil : Simbec Research

A clinical research study of ATX2417 and Placebo for the treatment of Allergy

Newcastle upon Tyne : Newcastle general hospital

A clinical trial to evaluate treatments using Special Medical Food for patients with Allergy or Food Allergy

Newport : David Hyde Allergy Clinic - St. Mary's hospital

A clinical trial to evaluate treatments using Special Medical Food for patients with Allergy or Food Allergy

Southampton : Novartis Investigative Site

A clinical research study of QGE031, Omalizumab, Placebo to QGE031 and Placebo to omalizumab for the treatment of Asthma

Southampton : Southampton General Hospital

A clinical trial to evaluate treatments using Special Medical Food for patients with Allergy or Food Allergy